SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

The World Cup warning: Riots don’t start in the streets. They start online

“There’s a price where you have to say yes”: CyberArk founder on the $25 billion Palo Alto deal

"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"

“There is no better solution for Zim than the one we created”

Buzz

Most popular

Daily

Weekly

1

"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"

2

Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat

3

"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"

4

Echo: “Employees have become very good at identifying performative culture”

5

Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR

Cannabotech

2 stories about Cannabotech

תרופה לסרטן קנבוטקתרופה לסרטן קנבוטק

Record-breaking capital raise: Israel’s Cannabotech develops cannabis-based medical solutions to help people with pancreatic and colorectal cancer

10.11.20| By Cannabotech

Over recent months, it has become clear to the world that new and non-traditional pathways to developing medical solutions are required

אלחנן שקד מנכ"ל CANNABOTECH

Cannabotech wants to raise $6 million in Israel’s first crowdfunded share issuance

Developer of medical solutions based on botanical combinations of cannabis extracts and fungi is planning to become a public, non-traded startup company